These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. An update on the role of high-dose therapy with autologous or allogeneic stem cell transplantation in mantle cell lymphoma. Jacobsen E; Freedman A Curr Opin Oncol; 2004 Mar; 16(2):106-13. PubMed ID: 15075900 [TBL] [Abstract][Full Text] [Related]
30. Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi. Visco C; Chiappella A; Nassi L; Patti C; Ferrero S; Barbero D; Evangelista A; Spina M; Molinari A; Rigacci L; Tani M; Rocco AD; Pinotti G; Fabbri A; Zambello R; Finotto S; Gotti M; Carella AM; Salvi F; Pileri SA; Ladetto M; Ciccone G; Gaidano G; Ruggeri M; Martelli M; Vitolo U Lancet Haematol; 2017 Jan; 4(1):e15-e23. PubMed ID: 27927586 [TBL] [Abstract][Full Text] [Related]
31. The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL). Dawar R; Hernandez-Ilizaliturri F Best Pract Res Clin Haematol; 2012 Jun; 25(2):185-90. PubMed ID: 22687454 [TBL] [Abstract][Full Text] [Related]
32. An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma. Morabito F; Recchia AG; Vigna E; Botta C; Skafi M; Abu-Rayyan M; Atrash M; Galimberti S; Morabito L; Al-Janazreh H; Martino M; Cutrona G; Gentile M Expert Opin Pharmacother; 2020 Jan; 21(1):29-38. PubMed ID: 31738609 [No Abstract] [Full Text] [Related]
33. Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era? Chaudhary L; Kharfan-Dabaja MA; Hari P; Hamadani M Bone Marrow Transplant; 2013 Nov; 48(12):1489-96. PubMed ID: 23584438 [TBL] [Abstract][Full Text] [Related]
34. The antibody drug conjugate VLS-101 targeting ROR1 is effective in CAR T-resistant mantle cell lymphoma. Jiang VC; Liu Y; Jordan A; McIntosh J; Li Y; Che Y; Jessen KA; Lannutti BJ; Wang M J Hematol Oncol; 2021 Aug; 14(1):132. PubMed ID: 34454548 [TBL] [Abstract][Full Text] [Related]
35. A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma. Witzig TE; Nowakowski GS; Habermann TM; Goy A; Hernandez-Ilizaliturri FJ; Chiappella A; Vitolo U; Fowler N; Czuczman MS Ann Oncol; 2015 Aug; 26(8):1667-77. PubMed ID: 25712458 [TBL] [Abstract][Full Text] [Related]
36. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management. Vose JM Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436 [TBL] [Abstract][Full Text] [Related]
38. Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial. Zoellner AK; Unterhalt M; Stilgenbauer S; Hübel K; Thieblemont C; Metzner B; Topp M; Truemper L; Schmidt C; Bouabdallah K; Krauter J; Lenz G; Dürig J; Vergote V; Schäfer-Eckart K; André M; Kluin-Nelemans HC; van Hoof A; Klapper W; Hiddemann W; Dreyling M; Hoster E; Lancet Haematol; 2021 Sep; 8(9):e648-e657. PubMed ID: 34450102 [TBL] [Abstract][Full Text] [Related]
39. Follicular Lymphoma: a Focus on Current and Emerging Therapies. Cahill KE; Smith SM Oncology (Williston Park); 2022 Feb; 36(2):97-106. PubMed ID: 35180337 [TBL] [Abstract][Full Text] [Related]
40. RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106. Chen RW; Li H; Bernstein SH; Kahwash S; Rimsza LM; Forman SJ; Constine L; Shea TC; Cashen AF; Blum KA; Fenske TS; Barr PM; Phillips T; Leblanc M; Fisher RI; Cheson BD; Smith SM; Faham M; Wilkins J; Leonard JP; Kahl BS; Friedberg JW Br J Haematol; 2017 Mar; 176(5):759-769. PubMed ID: 27992063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]